Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells.

Histone acetylation plays an important role in regulating gene expressions by modulating chromatin structure. Histone deacetylase (HDAC) inhibitors have been reported to have an antifibrogenic effect in some organs, such as the liver, skin, and lung, but the underlying mechanisms remain to be clarified. In the kidney, bone morphologic protein 7 (BMP-7) and hepatocyte growth factor are reported to antagonize TGF-beta1-induced tubular epithelial-to-mesenchymal transition (EMT), but nothing is known concerning the effect of HDAC inhibitors on EMT. It was shown that trichostatin A (TSA), an HDAC inhibitor, prevented TGF-beta1-induced EMT in cultured human renal proximal tubular epithelial cells. Treatment with TGF-beta1 induced morphologic changes such as EMT in human renal proximal tubular epithelial cells. However, co-treatment with TSA completely prevented TGF-beta1-induced morphologic changes and significantly prevented TGF-beta1-induced downregulation of E-cadherin and upregulation of collagen type I. Treatment with TSA did not alter TGF-beta1-induced phosphorylation of Smad2 and Smad3 but induced several inhibitory factors of TGF-beta1 signals, such as inhibitors of DNA binding/differentiation 2 (Id2) and BMP-7. Chromatin immunoprecipitation assay confirmed that histone acetylation was involved in the downregulation of E-cadherin and upregulation of Id2 and BMP-7. These results suggest that TSA and other HDAC inhibitors could be new therapeutic agents for tubular EMT.

[1]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[2]  P. Howe,et al.  Disabled-2 (Dab2) Is Required for Transforming Growth Factor β-induced Epithelial to Mesenchymal Transition (EMT)* , 2005, Journal of Biological Chemistry.

[3]  E. Hammond,et al.  Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2–related protein Bad , 2005, Molecular Cancer Therapeutics.

[4]  G. Dressler,et al.  Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease , 2005, Nature Medicine.

[5]  H. Duan,et al.  Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas , 2005, Molecular and Cellular Biology.

[6]  F. Saatcioglu,et al.  Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells , 2005, The Prostate.

[7]  Clara Nervi,et al.  Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. , 2005, Cancer research.

[8]  Junwei Yang,et al.  A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. , 2004, Journal of the American Society of Nephrology : JASN.

[9]  Y. Yoo,et al.  Trichostatin A induces apoptosis of p815 mastocytoma cells in histone acetylation- and mitochondria-dependent fashion. , 2004, International journal of oncology.

[10]  K. Miyazono,et al.  A role for Id in the regulation of TGF-β-induced epithelial–mesenchymal transdifferentiation , 2004, Cell Death and Differentiation.

[11]  L. Poellinger,et al.  Induction of ID2 Expression by Hypoxia-inducible Factor-1 , 2004, Journal of Biological Chemistry.

[12]  A. Nakao,et al.  Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction. , 2004, Kidney international.

[13]  Youhua Liu.  Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. , 2004, American journal of physiology. Renal physiology.

[14]  Youhua Liu,et al.  Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. , 2004, Journal of the American Society of Nephrology : JASN.

[15]  Raimund Hirschberg,et al.  Bone Morphogenetic Protein-7 Signals Opposing Transforming Growth Factor β in Mesangial Cells* , 2004, Journal of Biological Chemistry.

[16]  C. Heldin,et al.  Id2 and Id3 Define the Potency of Cell Proliferation and Differentiation Responses to Transforming Growth Factor β and Bone Morphogenetic Protein , 2004, Molecular and Cellular Biology.

[17]  Hanqiao Liu,et al.  Phenylbutyrate decreases type I collagen production in human lung fibroblasts , 2004, Journal of cellular biochemistry.

[18]  Tetsuhiro Tanaka,et al.  Transdifferentiation of cultured tubular cells induced by hypoxia. , 2004, Kidney international.

[19]  R. Kalluri,et al.  The role of epithelial-to-mesenchymal transition in renal fibrosis , 2004, Journal of Molecular Medicine.

[20]  Junwei Yang,et al.  Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling. , 2003, Journal of the American Society of Nephrology : JASN.

[21]  A. Roberts,et al.  Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. , 2003, The Journal of clinical investigation.

[22]  S. Klahr,et al.  Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. , 2003, Kidney international. Supplement.

[23]  Junwei Yang,et al.  Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis , 2003 .

[24]  R. Kalluri,et al.  BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.

[25]  R. Maestro,et al.  Role of Caspases, Bid, and p53 in the Apoptotic Response Triggered by Histone Deacetylase Inhibitors Trichostatin-A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA)* , 2003, Journal of Biological Chemistry.

[26]  Junwei Yang,et al.  Transforming Growth Factor-β1 Potentiates Renal Tubular Epithelial Cell Death by a Mechanism Independent of Smad Signaling* , 2003, The Journal of Biological Chemistry.

[27]  S. Klahr.  The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function. , 2003, Journal of nephrology.

[28]  G. Gilkeson,et al.  Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. , 2003, The Journal of clinical investigation.

[29]  J. Fujimoto,et al.  Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. , 2002, Kidney international.

[30]  D. Schuppan,et al.  Trichostatin A, a Histone Deacetylase Inhibitor, Suppresses Collagen Synthesis and Prevents TGF-β1-Induced Fibrogenesis in Skin Fibroblasts , 2002 .

[31]  D. Warburton,et al.  Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[32]  J. Downward,et al.  Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis , 2002, The Journal of Cell Biology.

[33]  H. Moses,et al.  Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.

[34]  D. Schuppan,et al.  A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture , 1999, Hepatology.

[35]  R. Kalluri,et al.  Early role of Fsp1 in epithelial-mesenchymal transformation. , 1997, American journal of physiology. Renal physiology.

[36]  Lucia Altucci,et al.  Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.

[37]  R. Spanagel,et al.  ERRATUM: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.

[38]  Youhua Liu.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.

[39]  Junwei Yang,et al.  Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. , 2002, Journal of the American Society of Nephrology : JASN.